Article
Epidemiological and clinicopathological features of KRAS, NRAS, BRAF mutations and MSI in Chinese patients with stage I-III colorectal cancer.
Medicine - 5 Apr 2024
Wang Weicheng, Wang Rui, Han Xiao, Zhang Wei, Zhu Lijun, Gu Yanhong
Abstract excerpt
The selection of appropriate treatment modalities based on the presence or absence of mutations in KRAS, NRAS, BRAF, and the microsatellite instability (MSI) status has become a crucial consensus in colorectal cancer (CRC) therapy. However, the distribution pattern of these genetic mutations and the prevalence of MSI status in Chinese stage I-III CRCs remain unclear. We retrospectively analyzed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
